Company Data

Sensasure Technologies Inc Ordinary Shares

Price Target
Refer to Report
52wk Range
$ - $
Advanced Market Data


SensaSure Technologies, Inc. is a medical technology company. The Company is engaged in supplying a device and method to collect a breath sample for lab-based analysis. The Company’s method is known as ExaBreath (EB) and it can collect, extract, detect and identify non-volatile compounds present in every exhaled breath by utilizing existing lab-based testing infrastructure and procedures. EB is applicable in toxicology, pharmacology, and clinical biochemistry. EB enhances the user experience in a range of applications and markets, such as workplace drug testing, anti-doping in sports, law enforcement, e-health, and telemedicine. The Company’s testing methodology is a non-invasive way to collect chemicals in breath, for disease detection, exposure monitoring, and drug metabolism. EB detects a range of exogenous substances, such as drugs of abuse (narcotics), therapeutic drugs (antibiotics), and performance-enhancing drugs used in sports (stimulants), as well as many other compounds.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy